These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24392350)

  • 21. Gangliosides and autoimmune diabetes.
    Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
    Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate antigens as targets for active specific immunotherapy.
    Ragupathi G
    Cancer Immunol Immunother; 1996 Nov; 43(3):152-7. PubMed ID: 9001568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gangliosides as therapeutic targets for cancer.
    Fredman P; Hedberg K; Brezicka T
    BioDrugs; 2003; 17(3):155-67. PubMed ID: 12749752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy.
    Bartish M; Del Rincón SV; Rudd CE; Saragovi HU
    Front Immunol; 2020; 11():564499. PubMed ID: 33133075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody recognition of aberrant glycosylation on the surface of cancer cells.
    Soliman C; Yuriev E; Ramsland PA
    Curr Opin Struct Biol; 2017 Jun; 44():1-8. PubMed ID: 27821276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immobilized glycolipids from human diploid fibroblasts inhibit DNA synthesis of cultured human fibroblasts.
    Janik-Schmitt B; Oesch F; Wieser RJ
    Exp Cell Res; 1987 Mar; 169(1):15-24. PubMed ID: 3817011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in renal cell cancer immunotherapy.
    Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
    Expert Opin Biol Ther; 2007 May; 7(5):727-37. PubMed ID: 17477809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate-containing molecules as potential biomarkers in colon cancer.
    Joo EJ; Weyers A; Li G; Gasimli L; Li L; Choi WJ; Lee KB; Linhardt RJ
    OMICS; 2014 Apr; 18(4):231-41. PubMed ID: 24502776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qualitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1 alpha) from Eb cells.
    Murayama K; Levery SB; Schirrmacher V; Hakomori S
    Cancer Res; 1986 Mar; 46(3):1395-402. PubMed ID: 3484680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells.
    Han YY; Liu HY; Han DJ; Zong XC; Zhang SQ; Chen YQ
    Biochem Pharmacol; 2013 Nov; 86(9):1254-62. PubMed ID: 23962446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of Naturally Occurring Human Antibodies Against Gangliosides by ELISA.
    Hernández AM; Rodríguez-Zhurbenko N
    Methods Mol Biol; 2017; 1643():179-186. PubMed ID: 28667538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis.
    Bousseau S; Vergori L; Soleti R; Lenaers G; Martinez MC; Andriantsitohaina R
    Pharmacol Ther; 2018 Nov; 191():92-122. PubMed ID: 29909237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers.
    Rossig C; Kailayangiri S; Jamitzky S; Altvater B
    Front Oncol; 2018; 8():513. PubMed ID: 30483473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Alterations of proteins and lipids glycosylation in pancreatic diseases].
    Gruszewska E; Chrostek L
    Pol Merkur Lekarski; 2011 Jan; 30(175):52-5. PubMed ID: 21542246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered glycosylation of mucin glycoproteins in colonic neoplasia.
    Kim YS
    J Cell Biochem Suppl; 1992; 16G():91-6. PubMed ID: 1469909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo incorporation of [2-14C]mevalonic acid into rat brain complex glycolipids: characterization of glycosylsterols in mammalian brain.
    Hungund BL; Dayal B; Dayal VK; Salen G
    Chem Phys Lipids; 1994 Feb; 69(2):167-73. PubMed ID: 8181105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolipid changes in murine myelogenous leukemias: neutral glycolipids as markers for specific populations of leukemias.
    Ariga T; Yoshida K; Nemoto K; Seki M; Miyatani N; Yu RK
    Biochemistry; 1991 Aug; 30(32):7953-61. PubMed ID: 1868069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycoimmunomics of human cancer: current concepts and future perspectives.
    Ravindranath MH; Yesowitch P; Sumobay C; Morton DL
    Future Oncol; 2007 Apr; 3(2):201-14. PubMed ID: 17381420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.